https://www.bioworld.com/articles/706053-hangzhou-zhongmei-huadong-pharmaceutical-discovers-new-gtpase-kras-inhibitors-for-cancer?v=preview
Hangzhou Zhongmei Huadong Pharmaceutical discovers new GTPase KRAS inhibitors for cancer | BioWorld
Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd. has described GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.
kras inhibitorshangzhoupharmaceuticaldiscoversnew
https://theamericanjournals.com/index.php/tajas/article/view/6270
The Potential of Pan-KRAS Inhibitors in the Treatment of KRAS-Mutant Leukemias | The American...
The American Journals publishes peer-reviewed research articles and scholarly insights across multiple disciplines. Explore rigorous studies, expert...
kras inhibitorspotentialpantreatmentmutant
https://mediamedic.co/apple-2023-combining-kras-inhibitors-may-enhance-immunotherapeutic-response-in-liver-cancer-patients-2/?php%20echo%20wp_logout_url(%20home_url()%20);%20?
APPLE 2023 | Combining KRAS inhibitors may enhance immunotherapeutic response in liver cancer...
Jan 17, 2024 - Hepatocellular carcinoma (HCC) is the most common malignant liver tumor in our country, posing a significant threat to the lives and health of our people....
kras inhibitorsliver cancerapplecombiningmay
https://www.aacr.org/blog/tag/kras-inhibitors/
KRAS inhibitors Archives - American Association for Cancer Research (AACR)
kras inhibitorsamerican associationcancer researcharchivesaacr
https://oncodaily.com/insight/101788
Simona Cristea: The multi-facet process of resistance to KRAS inhibitors in pancreatic cancer -...
Jul 11, 2024 - Simona Cristea: The multi-facet process of resistance to KRAS inhibitors in pancreatic cancer / Andrew Aguirre, Anirban Maitra, Break Through Cancer, cancer,
kras inhibitorspancreatic cancersimonamultifacet
https://pure.ecnu.edu.cn/zh/publications/structure-based-discovery-of-active-pan-kras-inhibitors-targeting/
Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling...
kras inhibitorsstructurebaseddiscoveryactive
https://www.ebi.ac.uk/chembl/explore/document/CHEMBL5634082
Document: Recent advances in the development of inhibitors targeting KRAS-G12C and its related...
Report card for Document Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways. (CHEMBL5634082). Eur J Med Chem, The...
recent advancesthe developmentdocumentinhibitorstargeting